Acute and chronic fixation for subcutaneous electrodes

• US 20040230282A1
• Filed: 12/23/2003
• Published: 11/18/2004
• Est. Priority Date: 04/11/2003
• Status: Abandoned Application

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Shiroff, Jason Alan, Wagner, Darrell Orvin, Cates, Adam W., Heil, Ron, Lindstrom, Curtis Charles, Kelley, Pete
• Application Number:
  US10/745,398
• Publication Number:
  US 20040230282A1
• Time in Patent Office: Days
• US Class Current: 607/126
• CPC Class Codes: A61B 17/3203 Fluid jet cutting instruments
• CPC Class Codes: A61B 17/3415 for introducing tubes or catheters, e.g. gastrostomy tubes, drain catheters A61B17/3417 takes precedence; body piercing catheter guide needles A61M25/06
• CPC Class Codes: A61B 17/3417 Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating syringe needles A61M5/32; dilators A61M29/00
• CPC Class Codes: A61B 2017/00243 cardiac
• CPC Class Codes: A61B 2017/00247 Making holes in the wall of the heart, e.g. laser Myocardial revascularization
• CPC Class Codes: A61B 2017/320044 Blunt dissectors
• CPC Class Codes: A61B 2017/320084 Irrigation sleeves
• CPC Class Codes: A61B 2018/00392 Transmyocardial revascularisation
• CPC Class Codes: A61B 2090/3945 Active visible markers, e.g. light emitting diodes
• CPC Class Codes: A61B 2217/005 with suction drainage system
• CPC Class Codes: A61B 2217/007 with irrigation system
• CPC Class Codes: A61B 90/30 Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 1/0568 with drug delivery
• CPC Class Codes: A61N 1/0587 Epicardial electrode systems; Endocardial electrodes piercing the pericardium
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

Implantable subcutaneous devices and methods incorporating a lead and/or electrode for cardiac monitoring and intervention, the lead employing chronic fixation elements including, for example, ridges, grooves, surface roughness, porosity, combined with acute fixation elements such as, for example, a suture site. A method of implanting subcutaneous leads may involve providing a lead comprising a lead body, an electrode, an acute fixation element, and one or more chronic fixation elements, and securing one or both of the lead body and the electrode to subcutaneous non-intrathoracic tissue at one or more fixation sites using the fixation elements. The method may involve: introducing a sheath into a subcutaneous non-intrathoracic body location of a patient; providing a lead comprising a lead body and an electrode; advancing the lead through the sheath and to the subcutaneous non-intrathoracic body location; fixing the lead to subcutaneous non-intrathoracic tissue; and removing the sheath from the patient.

Claims

1. An implantable lead, comprising:

a lead body;

a cardiac electrode supported by the lead body, the cardiac electrode configured for subcutaneous non-intrathoracic placement within a patient;

an acute fixation element provided on the implantable lead, the acute fixation element configured to acutely secure one or both of the lead body and the cardiac electrode to the subcutaneous non-intrathoracic tissue; and

a chronic fixation element provided on the implantable lead, the chronic fixation element configured to chronically secure one or both of the cardiac electrode and the lead body in the subcutaneous non-intrathoracic tissue.

2. The lead according to claim 1, wherein the chronic fixation element comprises a textured surface configured to promote tissue ingrowth.

3. The lead according to claim 2, wherein the textured surface comprises ridges.

4. The lead according to claim 3, wherein the ridges are angled diagonally with respect to a longitudinal axis of the lead.

5. The lead according to claim 2, wherein the textured surface comprises grooves.

6. The lead according to claim 5, wherein the grooves are angled diagonally with respect to a longitudinal axis of the lead.

7. The lead according to claim 5, wherein the grooves form a cross-hatch pattern relative to a longitudinal axis of the lead.

8. The lead according to claim 1, wherein the chronic fixation element comprises one or more porous regions to promote tissue ingrowth.

9. The lead according to claim 1, wherein the chronic fixation element comprises one or more passive fixation elements selected from the group consisting of tines, tines with barbs, sponges, textured surfaces, and porous regions.

10. The lead according to claim 1, wherein the acute fixation element is a helical coil.

11. The lead according to claim 1, wherein the acute fixation element comprises a suture attachment site.

12. An implantable lead system, comprising:

a lead comprising a lead body and a cardiac electrode, the lead configured for subcutaneous non-intrathoracic placement within a patient;

an acute fixation element provided on the lead, the acute fixation element configured to acutely secure one or both of the lead body and the cardiac electrode to the subcutaneous non-intrathoracic tissue;

a chronic fixation element provided on the lead, the chronic fixation element configured to secure one or both of the cardiac electrode and the lead body in the subcutaneous non-intrathoracic tissue; and

a delivery apparatus comprising a sheath configured to introduce the lead to a desired subcutaneous non-intrathoracic location within the patient.

13. The lead system according to claim 12, wherein the chronic fixation element comprises a textured surface to promote tissue ingrowth.

14. The lead system according to claim 12, wherein the chronic fixation element comprises one or more porous regions to promote tissue ingrowth.

15. The lead system according to claim 12, wherein the chronic fixation element comprises tines.

16. The lead system according to claim 12, wherein the acute fixation element comprises tines.

17. The lead system according to claim 12, wherein the chronic fixation element comprises an expanding element in or on the lead.

18. The lead system according to claim 12, wherein the acute fixation element comprises an expanding element in or on the lead.

19. The lead system according to claim 12, wherein the acute fixation element comprises a helical coil.

20. The lead system according to claim 12, wherein the acute fixation element comprises a non-polymeric additive in or on the lead body and wherein the chronic fixation element comprises pores from the dissolution of the non-polymeric additive that promote tissue ingrowth.

21. The lead system according to claim 12, wherein the sheath comprises a longitudinal pre-stress line arrangement to facilitate sheath separation during retraction of the sheath from the patient.

22. A method of lead stabilization, comprising:

providing a lead comprising a lead body, a cardiac electrode, and a plurality of fixation elements;

acutely securing one or both of the lead body and the cardiac electrode to subcutaneous non-intrathoracic tissue using an acute fixation element from the plurality of fixation elements; and

chronically securing one or both of the lead body and the cardiac electrode to the subcutaneous non-intrathoracic tissue using a chronic fixation element from the plurality of fixation elements.

23. The method according to claim 22, wherein acutely securing the one or both of the lead body and the cardiac electrode to the subcutaneous non-intrathoracic tissue comprises using a helical coil to acutely secure the one or both of the lead body and the cardiac electrode to the subcutaneous non-intrathoracic tissue.

24. The method according to claim 22, wherein acutely securing one or both of the lead body and the cardiac electrode to the subcutaneous non-intrathoracic tissue comprises using a suture to acutely secure the one or both of the lead body and the cardiac electrode to the subcutaneous non-intrathoracic tissue.

25. The method according to claim 22, wherein chronically securing the one or both of the lead body and the cardiac electrode comprises promoting tissue ingrowth between the one or both of the lead body and the cardiac electrode and the subcutaneous non-intrathoracic tissue.

26. The method of according to claim 22, wherein chronically securing the one or both of the lead body and the cardiac electrode comprises promoting tissue ingrowth between at least some of the plurality of fixation elements and the subcutaneous non-intrathoracic tissue.

27. The method according to claim 26, wherein the at least some of the plurality of fixation elements comprise a textured surface of the lead.

28. The method according to claim 26, wherein the at least some of the plurality of fixation elements comprise a porous surface of the lead.

29. The method of according to claim 22, wherein chronically securing the one or both of the lead body and the cardiac electrode comprises expandably securing using an expandable element in or on the lead.

30. The method of according to claim 22, wherein chronically securing the one or both of the lead body and the cardiac electrode comprises using tines to secure the lead in the subcutaneous non-intrathoracic tissue.

31. The method of according to claim 22, wherein acutely securing the one or both of the lead body and the cardiac electrode comprises using tines to secure the lead in the subcutaneous non-intrathoracic tissue.

32. The method of according to claim 22, wherein acutely securing the one or both of the lead body and the cardiac electrode comprises expandably securing using an expandable element in or on the lead.

33. An implantable lead, comprising:

a lead body;

a cardiac electrode supported by the lead body, the cardiac electrode configured for subcutaneous non-intrathoracic placement in a patient;

means for acutely fixing one or both of the lead body and cardiac electrode within the subcutaneous non-intrathoracic tissue; and

means for chronically fixing one or both of the lead body and cardiac electrode within the subcutaneous non-intrathoracic tissue.

34. The lead according to claim 33, further comprising means for delivering the lead to a desired location in the subcutaneous non-intrathoracic tissue.

35. The lead according to claim 33, wherein the acute fixing means comprises means for passively fixing the one or both of the lead body and cardiac electrode within the subcutaneous non-intrathoracic tissue

36. The lead according to claim 33, wherein the acute fixing means comprises a helical coil.

37. The lead according to claim 33, wherein the chronic fixing means comprises tines.

38. The lead according to claim 33, wherein the chronic fixing means comprises apertures for promoting tissue ingrowth between the one or both of the lead body and cardiac electrode and the subcutaneous non-intrathoracic tissue.

39. The lead according to claim 33, wherein the chronic fixing means comprises means for promoting tissue ingrowth between the one or both of the lead body and cardiac electrode and the subcutaneous non-intrathoracic tissue.

40. A method of lead delivery and stabilization, comprising:

introducing a sheath into a subcutaneous non-intrathoracic body location of a patient;

providing a lead comprising a lead body and a cardiac electrode;

advancing the lead through the sheath and to the subcutaneous non-intrathoracic body location;

acutely fixing the lead to the subcutaneous non-intrathoracic tissue;

chronically fixing the lead to the subcutaneous non-intrathoracic tissue; and

removing the sheath from the patient.

41. The method according to claim 40, wherein removing the sheath comprises longitudinally splitting the sheath when retracting the sheath from the patient.

42. The method according to claim 40, wherein removing the sheath comprises enabling a plurality of fixation elements for passive engagement with the subcutaneous non-intrathoracic tissue.

43. The method according to claim 40, wherein advancing the lead through the sheath comprises modifying a position or an orientation of a plurality of passive fixation elements provided on one or both of the lead body and cardiac electrode.

44. The method according to claim 40, wherein acutely fixing the lead comprises expandingly fixing the lead using a non-polymeric additive in or on the lead body and wherein chronically fixing the lead comprises promoting tissue ingrowth by providing pores from the dissolution of the non-polymeric additive.

45. The method according to claim 40, wherein chronically fixing the lead comprises promoting tissue ingrowth to fix one or both of the lead body and the electrode to the subcutaneous non-intrathoracic tissue.

46. The method according to claim 40, wherein acutely fixing the lead comprises suturing the electrode to the subcutaneous non-intrathoracic tissue.

47. The method according to claim 40, wherein acutely fixing the lead comprises rotating at least a portion of a helical fixation element thereby fixing the helical fixation element in the subcutaneous non-intrathoracic tissue.